ABUS
Arbutus Biopharma Corporation Common StockData: 2026-09-11
Quick Stats
Sep 11, 202647.1
AI Score
HOLD0.5
Volume Ratio
TBA
Next Earnings
16
+ve Days (30d)
12
-ve Days (30d)
ABUS Price vs Max Options Open Interest
How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.
ABUS Max Change In Options Open Interest
How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.
ABUS Options - Sort by Max open Interest (near term)
14th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ABUS Daily Out of Money Options - Sort by Max open Interest (near term)
14th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ABUS Daily In the Money Options - Sort by Max open Interest (near term)
14th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ABUS Most Active Options by Volume(near term)
14th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ABUS Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Volume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
ABUS Stock Summary
Last updated Sep 11, 2026
ABUS is currently trading at $5.12, positioned above its 200-day moving average of $4.51, indicating a long-term uptrend. The stock has a 52-week range of $3.5 to $5.45.
Technical Analysis: The 50-day moving average stands at $4.79, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 59.959, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.155, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates ABUS at 47.1/100 with a HOLD recommendation.
ABUS (Arbutus Biopharma Corporation Common Stock) Indicators
Last updated Sep 11, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 59.959 |
| CMF (20) | -0.155 |
| ROC (10) | -0.967 |
| ADX (14) | 30.763 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.127 |
| AROONOSC (14) | -42.857 |
| WILLAMS %R (14) | -55.556 |
| MFI (14) | 38.468 |
ABUS Candlestick Patterns
Validated patterns fired in the last 10 sessions. Hit rate = how often price moved in the signal's direction within 5 trading days (backtest: 2.7M signals, 3,500 liquid stocks, Feb 2025–Sep 2026). Baseline: a random stock closes higher 5 days later 53% of the time. Click a row to see the candle on the chart.
| Date | Pattern | Signal | 5-Day Hit Rate | Edge vs Baseline | Sample |
|---|---|---|---|---|---|
| Sep 02 | Gravestone Doji | Bullish | 55.2% | +2.2 pts | 21200 |
These are statistical tilts, not standalone trade setups. Only patterns with a measured edge are shown — roughly 50 of 60 textbook patterns showed no edge and are hidden.
Arbutus Biopharma Corporation Common Stock is above both the 50 Day and 200 Day SMA which is considered Bullish.
ABUS Moving Averages Analysis
Arbutus Biopharma Corporation Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Sep 11, 2026
Arbutus Biopharma Corporation Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Sep 11, 2026
ABUS (Arbutus Biopharma Corporation Common Stock) Simple Moving Averages
Moving Averages are last updated Sep 11, 2026
| Days | MA |
|---|---|
| 10 | 5.12 |
| 20 | 5.06 |
| 30 | 4.88 |
| 50 | 4.79 |
| 100 | 4.58 |
| 200 | 4.51 |
ABUS Fundamental Analysis
| P/E (Forward) | 10.2459 |
| P/E (Trailing) | 6.481 |
| Market Cap ($) | 1.0 billion |
| Earnings/Share ($) | 0.79 |
| Net Profit Margin (%) | 0.8423 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 1.027 |
| EPS Estimate Next Year ($) | -0.111 |
| WallStreet Target Price ($) | 5.51 |
| Most Recent Quarter |
Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.